Catherine Madigan
Chief Tech/Sci/R&D Officer at SYNDAX PHARMACEUTICALS, INC.
Net worth: 743 215 $ as of 30/04/2024
Catherine Madigan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/03/2022 | - |
| Corporate Officer/Principal | - | 01/03/2022 |
Career history of Catherine Madigan
Former positions of Catherine Madigan
| Companies | Position | Start | End |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - | - |
| SYROS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Catherine Madigan
| Dartmouth College | Undergraduate Degree |
| Keck School of Medicine of USC | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Catherine Madigan
- Experience
